On 3/1/24, Abeona Therapeutics Inc (NASDAQ: ABEO) stock enjoyed a major increase of 13.2%, closing at $7.81. Moreover, this advance was accompanied by exceptionally high trading volume at 349% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 16.6% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ABEO is expected to continue to be Value Creation neutral.
Abeona Therapeutics has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Abeona Therapeutics has a very low Appreciation Score of 1 but a very high Power Rating of 93, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment